The NCCN clinical practice guidelines in oncology: A primer for users

JNCCN Journal of the National Comprehensive Cancer Network

Volumn 1, Issue 1, 2003, Pages 5-13

  Winn, Rodger J ^a   McClure, Joan ^a  

^a National Comprehensive Cancer Network   (United States)

Author keywords

Health planning; Medical oncology; NCCN; Neoplasms; Outcome and process assessment; Practice guidelines

Indexed keywords

ARTICLE; HUMAN; NEOPLASM; ONCOLOGY; PRACTICE GUIDELINE; TREATMENT OUTCOME;

HUMANS; MEDICAL ONCOLOGY; NEOPLASMS; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE);

EID: 79959310058     PISSN: 15401405     EISSN: 15401413     Source Type: Journal    
DOI: 10.6004/jnccn.2003.0003     Document Type: Review

References (66)

1. National Quality Forum. A National Framework For Health Care Quality Measurement And Reporting: A Consensus Report. Washington, DC: The National Quality Forum; 2002.
2. Hewitt M, Simons P. Ensuring Quality Cancer Care. Washington, DC: Institute of Medicine; 1999.
3. Grimshaw JM. Effect of clinical guidelines on medical practice: A systematic review of rigorous evaluations. Lancet 1993;342:1317-1322.
4. Smith TJ, Hillner BE. Ensuring quality cancer care by the use of clinical practice guidelines and critical pathways. J Clin Oncol 2001;19:2886-2897.
5. Woolf SH, Grol R, Hutchinson A et al. Clinical guidelines: Potential benefits, limitations, and harms of clinical guidelines. BMJ 1999;318:527-530.
6. Feder G, Eccles M, Grol R et al. Using clinical guidelines. BMJ 1999;318:728-730.
7. Field MJ, Lohr KN, eds. Clinical Practice Guidelines: Direction for a New Program. Washington, DC: National Academy Press; 1990.
8. Eddy DM. Practice policies: What are they? JAMA 1990;263: 877-879.
9. Capron AM. Practice guidelines: How good are medicine's new recipes? J Law Med Ethics 1995;23:47-48.
10. Winn RJ, Brown NH. The NCCN development process. Oncology 1999;13:28-32.
11. Parke EP, Fink A, Brook RH et al. Physician ratings of appropriate medical indications for six medical and surgical procedures. Am J Pub Health 1986;76:766-772.
12. Woolf SH. Practice guidelines: a new reality in medicine. III. Impact on patient care. Arch Intern Med 1993; 153: 2646-2655.
13. Haldorn DC. Use of algorithms in clinical guideline development. In: Clinical Practice Guideline Development: Methodology Perspectives. Rockville, MD: Agency for Health Care Policy and Research, Public Health Service; 1993:93-104.
14. Parmley W. Clinical practice guidelines: Does the cookbook have enough recipes? JAMA 1994:272:1374-1375.
15. Osaba D. A taxonomy of the uses of health-related quality-of- life instruments in cancer care and the clinical meaningfulness of the results. Med Care 2002;40(suppl 3):31-38.
16. Buchan H. Clinical guidelines: Acceptance and promotion. Qual Health Care 1993;2:213-214.
17. Czaja R, McFall SL, Warnecke RB et al. Preferences of community physicians for cancer screening guidelines. Ann Intern Med 1994;120:602-608.
18. Ayanian JZ, Guadagnoli E. Variations in breast cancer treatment by patient and provider characteristics. Breast Cancer Res Treat 1996;40:65-74.
19. Winn RJ, Teng NNH. Clinical practice guidelines in the management of gynecologic malignancies. Hematol Oncol Clin North Am 1999;13:63-75.
20. Earle CC, Neumann PJ, Gelber RD et al. Impact of referral patterns on the use of chemotherapy for lung cancer. J Clin Oncol 2002;20:1786-1792.
21. Cleeland CS, Gonin R, Hatfield AK et al. Pain and its treatment in outpatients with metastatic cancer. N Engl J Med 1994;330:592-596.
22. Schriefer J. The synergy of pathways and algorithms: Two tools work better than one. J Qual Improve 1994;20:485-499.
23. Brook RH. Practice guidelines and practicing medicine: Are they compatible? JAMA 1989;262:3027-3031.
24. Berg AO, Atkins D, Tierney W. Clinical practice guidelines in practice and education. J Gen Intern Med 1997;12(Suppl 2):S25-S33.
25. Eddy DM. Anatomy of a decision. JAMA 1990;263:441-443.
26. Holmes-Rovner M, Llewellyn-Thomas H, Entwistle V et al. Patient choice modules for summaries if clinical effectiveness: A proposal. BMJ 2001;323:664-667.
27. Kravitz RL, Melnikow J. Engaging patients in medical decision-making: The end is worthwhile, but the means need to be more practical. BMJ 2001;323:584-585.
28. Grol R. Improving quality of medical care: Building bridges among professional pride, payer profit, and patient satisfaction. JAMA 2001:286:2578-2585.
29. Donabedian A. The quality of care: How can it be assessed? JAMA 1988;260:1743-1748.
30. Agency for Health Care Policy and Research. Using Clinical Practice Guidelines to Evaluate Quality of Care. Washington, DC: ACHPR publication no. 95-0045; March 1995.
31. Weeks J. Outcomes assessment in the NCCN: 1998 update. Oncology 1999;13:69-72.
32. McKee M, Clarke A. Guidelines, enthusiasms, uncertainty, and limits to purchasing. BMJ 1995;310:101-104.
33. Morrison J, Carroll L, Twaddle S et al. Pragmatic randomized controlled trial to evaluate guidelines for the management of infertility across the primary-secondary care interface. BMJ 2001;322:1282-1284.
34. Pauly MV. Practice guidelines: Can they save money? Should they? J Law Med Ethics 1995;23:65-74.
35. Carpenter CE, Nash DB, Johnson NE. Evaluating the cost containment of potential clinical guidelines. Qual Rev Bull 1993;19:119-123.
36. Merlani P, Garnerin P, Diby M et al. Linking guideline to regular feedback to increase appropriate requests for clinical tests: Blood gas analysis in intensive care. BMJ 2001; 323:620-624.
37. Granata AV, Hillman AL. Competing practice guidelines: Using cost-effectiveness analysis to make optimal decisions. Ann Intern Med 1998;128:56-63.
38. Woolf SH. Practice guidelines, a new reality in medicine. II. Methods of developing guidelines. Arch Intern Med 1992;152:946-952.
39. Audet A-M, Greenfield S, Field M. Medical practice guidelines: current activities and future directions. Ann Intern Med 1990;113:709-714.
40. Eddy DE. Clinical decision-making: From theory to practice: Guidelines for policy statements: the explicit approach. JAMA 1990;263:2239-2240.
41. Shekelle PG, Woolf SH, Eccles M et al. Clinical guidelines: Developing guidelines. BMJ 1999;318:593-596.
42. Shaneyfeldt TM, Mayo-Smith MF, Rothwangl J. Are guidelines following guidelines? The methodological quality of clinical practice guidelines in the peer-reviewed adult literature. JAMA 1999;281:1900-1905.
43. Woolf SH, DiGuiseppi CG, Atkins D et al. Developing evidence-based clinical practice guidelines: Lessons learned by the US Preventive Services Task Force. Ann Rev Pub Health 1996;17:511-538.
44. Cook DJ, Greengold NL, Ellrodt AG et al. The relationship between systematic reviews and practice guidelines. Ann Intern Med 1997;127:210-216.
45. Browman G. Development and aftercare of clinical guidelines: The balance between rigor and pragmatism. JAMA 2001; 286:1509-1511.
46. Djulbegovic B, Hadley T. Evaluating the quality of clinical guidelines: Linking decisions to medical evidence. Oncology 1998;12:310-314.
47. Winn RJ. NCCN Guideline development: Some lessons learned. Cancer Control 2001;8:11-14.
48. Pearson SD, Margolis CZ, Davis S et al. Is consensus reproducible? A study of an algorithmic guidelines development process. Med Care 1995;33:643-660.
49. Winn RJ, Brown NH, Botnick WZ. Reproducibility of guidelines: A comparison of the NCCN and ASCO lung cancer guidelines. Oncology 1999;13:35-39.
50. American Society of Clinical Oncology. Clinical practice guidelines for the treatment of unresectable non-small cell lung cancer. J Clin Oncol 1997;15:2996-3018.
51. NCCN non-small-cell lung cancer practice guidelines. Oncology 1996;14:81-111.
52. Spratt JS. The risky shift. J Surg Oncol 1991;48:1-3.
53. Fink A, Kosecoff J, Chassin M et al. Consensus methods: Characteristics and guidelines for use. Am J Pub Health 1984;74:979-983.
54. Edmonds JP, Day RO, Bertoch JV. The road to consensus: Considerations for the safe use and prescribing of COX-2-specific inhibitors. Med J Aust 2002;176;332-334.
55. Coulter I, Adams A, Shekelle P. Impact of varying panel membership on ratings of appropriateness in consensus panels: A comparison of a multi- and single disciplinary panel. Health Serv Res 1995;30:579-589.
56. Grilli R, Magrini N, Penna A et al. Practice guidelines developed by specialty societies: The need for a critical appraisal. Lancet 2000;355:103-106.
57. Glaser EM. Using behavioral science strategies for defining the state-of-the art. J Am Behav Sci 1980;16:79-92.
58. Shekelle P, Eccles MP, Grimshaw JM et al. When should guidelines be updated? BMJ 2001;323:155-157.
59. Shekelle PG, Ortiz E, Rhodes S et al. Validity of the Agency for Healthcare Research and Quality clinical practice guidelines: How quickly do guidelines become outdated? JAMA 2001;286:1461-1467.
60. Choudhry NK, Stelfox HT, Detsky AS. Relationship between authors of clinical practice guidelines and the pharmaceutical industry. JAMA 2002;287:612-617.
61. Van der Wyden MB. Clinical practice guidelines: Time to move the debate from the how to the who. Med J Austral 2002;176:304-305.
62. Harbour R, Miller J. A new system for grading recommendations in evidence-based guidelines. BMJ 2001;323:334-336.
63. Baillard DJ, Duncan PW. Role of population-based epidemiologic surveillance in clinical practice guideline development. In: Clinical Practice Guideline Development: Methodology Perspectives. Rockville, MD: Agency for Health Care Policy and Research, Public Health Service; 1993:93-104.
64. Cook DJ, Guyatt GH, Laupacis A et al. Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest 1992;102(suppl 4):S305-S311.
65. McNeill BJ, Shattuck L. Hidden barriers to the improvement in the quality of care. N Engl J Med 2001;345: 1612-1619.
66. Woolf SH, Lawrence RS. Preserving scientific debate and patient choice: Lessons from the Consensus Panel on mammography screening. JAMA 1997;278:2105-2107.